Chinese biotech firm Adagene plans $200m US IPO

Chinese biotech firm Adagene plans $200m US IPO

Adagene is a clinical stage oncology-based biotech company

Julia Fioretti

12 November, 2020

Adagene

Bring stories like this into your inbox every day.

Sign up for our newsletter - The Daily Brief
Subscribe to Newsletter

You may also like

Read more from Greater China

Nikkei Logo
DealStreetAsia Logo
About Us
Team
Advertise
Contact
Careers
Blog
Privacy Policy
Terms & Conditions
© Copyright DEALSTREETASIA 2014-2025 All rights reserved.